-
Signature
-
/s/ Veena Bhatia, Attorney-in-Fact for Cannon-Brookes Michael
-
Issuer symbol
-
TEAM
-
Transactions as of
-
23 Jun 2025
-
Net transactions value
-
-$1,476,877
-
Form type
-
4
-
Filing time
-
24 Jun 2025, 16:12:15 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Cannon-Brookes Michael |
CEO, Co-Founder, Director, 10%+ Owner |
C/O ATLASSIAN CORPORATION, 350 BUSH STREET, FLOOR 13, SAN FRANCISCO |
/s/ Veena Bhatia, Attorney-in-Fact for Cannon-Brookes Michael |
24 Jun 2025 |
0001666120 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TEAM |
Class A Common Stock |
Sale |
$85,752 |
-450 |
-0.98% |
$190.56 |
45,540 |
23 Jun 2025 |
See Footnote |
F1, F2, F3 |
| transaction |
TEAM |
Class A Common Stock |
Sale |
$732,466 |
-3,800 |
-8.3% |
$192.75 |
41,740 |
23 Jun 2025 |
See Footnote |
F1, F3, F4 |
| transaction |
TEAM |
Class A Common Stock |
Sale |
$143,894 |
-750 |
-1.8% |
$191.86 |
40,990 |
23 Jun 2025 |
See Footnote |
F1, F3, F5 |
| transaction |
TEAM |
Class A Common Stock |
Sale |
$37,688 |
-200 |
-0.49% |
$188.44 |
40,790 |
23 Jun 2025 |
See Footnote |
F1, F3, F6 |
| transaction |
TEAM |
Class A Common Stock |
Sale |
$467,367 |
-2,415 |
-5.9% |
$193.53 |
38,375 |
23 Jun 2025 |
See Footnote |
F1, F3, F7 |
| transaction |
TEAM |
Class A Common Stock |
Sale |
$9,710 |
-50 |
-0.13% |
$194.21 |
38,325 |
23 Jun 2025 |
See Footnote |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: